David A. Ramsay
2015
In 2015, David A. Ramsay earned a total compensation of $1M as Vice President and Chief Financial Officer at Halozyme Therapeutics, a 18% decrease compared to previous year.
Compensation breakdown
| Option Awards | $364,820 |
|---|---|
| Salary | $253,986 |
| Stock Awards | $386,680 |
| Other | $8,475 |
| Total | $1,013,961 |
Ramsay received $386.7K in stock awards, accounting for 38% of the total pay in 2015.
Ramsay also received $364.8K in option awards, $254K in salary and $8.5K in other compensation.
Rankings
In 2015, David A. Ramsay's compensation ranked 7,877th out of 13,638 executives tracked by ExecPay. In other words, Ramsay earned more than 42.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,877 out of 13,638 | 42nd |
Division Manufacturing | 2,987 out of 5,187 | 42nd |
Major group Chemicals And Allied Products | 1,079 out of 1,857 | 42nd |
Industry group Drugs | 872 out of 1,531 | 43rd |
Industry Biological Products, Except Diagnostic Substances | 151 out of 260 | 42nd |
Source: SEC filing on March 23, 2016.
Ramsay's colleagues
We found four more compensation records of executives who worked with David A. Ramsay at Halozyme Therapeutics in 2015.